A theoretical approach for the acylation/deacylation mechanisms of avibactam in the reversible inhibition of KPC-2

J Comput Aided Mol Des. 2021 Sep;35(9):943-952. doi: 10.1007/s10822-021-00408-3. Epub 2021 Jul 8.

Abstract

Klebsiella pneumoniae carbapenemase (KPC-2) is the most commonly encountered class A β-lactamase variant worldwide, which confer high-level resistance to most available antibiotics. In this article we address the issue by a combined approach involving molecular dynamics simulations and hybrid quantum mechanics/molecular mechanics calculations. The study contributes to improve the understanding, at molecular level, of the acylation and deacylation stages of avibactam involved in the inhibition of KPC-2. The results show that both mechanisms, acylation and deacylation, the reaction occur via the formation of a tetrahedral intermediate. The formation of this intermediate corresponds to the rate limiting stage. The activation barriers are 19.5 kcal/mol and 23.0 kcal/mol for the acylation and deacylation stages, respectively. The associated rate constants calculated, using the Eyring equation, are 1.2 × 10-1 and 3.9 × 10-4 (s-1). These values allow estimating a value of 3.3 × 10-3 for the inhibition constant, in good agreement with the experimental value.

Keywords: Avibactam; Inhibition; KPC-2; QM/MM.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acylation
  • Amino Acid Sequence
  • Anti-Bacterial Agents / chemistry*
  • Anti-Bacterial Agents / pharmacology
  • Azabicyclo Compounds / chemistry*
  • Azabicyclo Compounds / pharmacology
  • Catalytic Domain
  • Klebsiella pneumoniae / enzymology*
  • Molecular Dynamics Simulation
  • Protein Binding
  • Protein Conformation
  • Thermodynamics
  • beta-Lactamase Inhibitors / chemistry*
  • beta-Lactamase Inhibitors / pharmacology
  • beta-Lactamases / metabolism*

Substances

  • Anti-Bacterial Agents
  • Azabicyclo Compounds
  • beta-Lactamase Inhibitors
  • avibactam
  • beta-Lactamases